*By Michael Teich*
Trade tensions between the U.S. and China are reaching new heights after the Trump administration proposed tariffs on an additional $200 billion worth of Chinese imports.
Stocks fell sharply on the news, with the Dow Industrials closing Wednesday down nearly 220 points. But some investors think the pullback could be an opportunity for investors.
"Put money to work today," said Kate Warne, Investment Strategist at Edward Jones. "The market is reacting to headline announcements."
"This is really a negotiating posture, rather than something that will go into effect."
Despite accelerating trade fears, Wall Street's attention should shift to corporate earnings season, according to Warne.
"Earnings will be a catalyst for stocks to move higher," she said. "It matters more than the trade tensions, in terms of the outlook for the market."
Banking giants JPMorgan and Citigroup report second quarter earnings on Friday. Netflix releases its results after the bell on Monday.
For the full segment, [click here.](https://cheddar.com/videos/this-is-the-reason-to-buy-the-next-market-dip)
Republican presidential candidate Vivek Ramaswamy tried to sway Iowa voters during Wednesday night's CNN Republican presidential town hall in Des Moines.
A judge says Donald Trump’s 2020 election interference case in Washington will be put on hold while the former president further pursues his claims that he is immune from prosecution.
The Supreme Court on Wednesday said it will hear an appeal that could upend hundreds of charges stemming from the Capitol riot, including against former President Donald Trump.
The Federal Reserve kept its key interest rate unchanged Wednesday for a third straight time, and its officials signaled that they expect to make three quarter-point cuts to their benchmark rate next year.
Hunter Biden on Wednesday defied a congressional subpoena to appear privately for a deposition before Republican investigators who have been digging into his business dealings, insisting outside the U.S. Capitol that he will only testify in public.
The Supreme Court agreed on Wednesday to take up a dispute over a medication used in the most common method of abortion in the United States, its first abortion case since it overturned Roe v. Wade last year.
